Clinical Trials Directory

Trials / Conditions / Recurrent Lung Small Cell Carcinoma

Recurrent Lung Small Cell Carcinoma

10 registered clinical trials studyying Recurrent Lung Small Cell Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTesting of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell
NCT05353439
National Cancer Institute (NCI)Phase 1
RecruitingTemozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung
NCT04919382
Dwight OwenPhase 2
Active Not RecruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced
NCT04514484
National Cancer Institute (NCI)Phase 1
RecruitingTesting if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids
NCT04804644
NRG OncologyPhase 3
Active Not RecruitingRandomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell C
NCT03896503
National Cancer Institute (NCI)Phase 2
CompletedCisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small
NCT03382561
National Cancer Institute (NCI)Phase 2
TerminatedNavitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
NCT03366103
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingTemozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT01638546
National Cancer Institute (NCI)Phase 2
TerminatedRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metas
NCT01217411
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-S
NCT00453154
National Cancer Institute (NCI)Phase 1 / Phase 2